Effect of Ambroxol in Diabetic Peripheral Neuropathy
Status:
Not yet recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
A prospective, randomized, controlled study will be conducted at Department of Endocrinology,
Faculty of Medicine, Ain Shams University, assessing the efficacy of Ambroxol addition on the
clinical outcome and inflammatory markers in Diabetic peripheral neuropathy patients